Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H25NO |
Molecular Weight | 247.3758 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOCCNC1(CCCCC1)C2=CC=CC=C2
InChI
InChIKey=PRQVCBDFWYTXDD-UHFFFAOYSA-N
InChI=1S/C16H25NO/c1-2-18-14-13-17-16(11-7-4-8-12-16)15-9-5-3-6-10-15/h3,5-6,9-10,17H,2,4,7-8,11-14H2,1H3
Molecular Formula | C16H25NO |
Molecular Weight | 247.3758 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4729 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19022226 |
|||
Target ID: CHEMBL3622 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19022226 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:31:43 GMT 2023
by
admin
on
Sat Dec 16 15:31:43 GMT 2023
|
Record UNII |
HR7BX09IBP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1072895-05-6
Created by
admin on Sat Dec 16 15:31:44 GMT 2023 , Edited by admin on Sat Dec 16 15:31:44 GMT 2023
|
PRIMARY | |||
|
46839345
Created by
admin on Sat Dec 16 15:31:44 GMT 2023 , Edited by admin on Sat Dec 16 15:31:44 GMT 2023
|
PRIMARY | |||
|
HR7BX09IBP
Created by
admin on Sat Dec 16 15:31:44 GMT 2023 , Edited by admin on Sat Dec 16 15:31:44 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
This metabolite was detected in rat urine. However, according to the journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
|
||
|
METABOLITE -> PARENT |
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
|
||
|
METABOLITE -> PARENT |
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
|